Oregon Health & Science University leaders say a federal drug discount pilot set to begin next year could create a ...

Chevron (NYSE: CVX) used its investor day in New York to signal a confident long-term outlook, unveiling a five-year plan ...

Non-automotive growth -- Expanded commercial traction in off-road autonomy (e.g., Caterpillar, Forterra), aerospace (Lake ...

Trailing Twelve-Month Core Product Sales -- $37 million, a company record, up from $33.8 million, with distributor and ...

Despite a dip in overall revenue, Linamar Corp (LIMAF) showcases resilience with robust Mobility segment performance and ...

"What they found was that of all new drugs approved in the last 20 years, 12% came from the SBIR/STTR program," said Jere Glover.

Virgin Galactic reported Q3 results Thursday. A look at the key highlights and what's next for the space stock.

The Company Achieves a 7% Increase in YTD Production, Reduces Net Debt, and Maintains Production and Capital Expenditure ...

Detailed price information for Peyto Exploration and Dvlpmnt Corp (PEY-T) from The Globe and Mail including charting and trades.

Moody’s Ratings downgraded Nike, Inc.’s debt ratings, based on the expectation that while Nike’s strategies will drive market share and profit margin recovery over time, the improvement will be slower ...

Spartan Delta posts 70% QoQ oil growth, stronger margins, and major Duvernay-driven expansion with proven asset strategy.

Advanced modeling powered by artificial intelligence (AI) indicates that Montauban may be more than a reclamation or ...